> DOV Pharmaceutical has released late-stage data showing that its non-narcotic painkiller bicifadine is superior to a placebo. Report
> Faced with a growing mountain of Vioxx litigation, Merck officials continue to insist that they are a strong and secure company capable of weathering the storm. Article
> Amarin shares were on the rise this morning on news that it had begun enrolling patients for a late-stage trial of its therapy for Huntington's disease. Story
> Genaera has raised $24.5 million in a direct equity placement. Release
> A group of companies plan to raise $4 billion to buy vaccines for the poor throughout the developing world. Story
> Chutes & Ladders: Zelos Therapeutics CEO Robert DuFresne has left the company. Release
And Finally… University of Connecticut scientist Jerry Yang is racing to clone human embryos and have them implanted in a patient before a life-threatening case of cancer brings his work to a halt. Story